GROUP ONE TRADING, L.P. - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$54,000
+1.9%
98,513
+0.6%
0.00%0.0%
Q1 2016$53,000
-56.9%
97,913
-28.4%
0.00%0.0%
Q4 2015$123,000
-2.4%
136,833
-12.0%
0.00%
-50.0%
Q3 2015$126,000
-77.7%
155,433
-17.1%
0.00%
-75.0%
Q2 2015$564,000
+121.2%
187,428
+79.8%
0.01%
+100.0%
Q1 2015$255,000
+140.6%
104,219
+150.4%
0.00%
+100.0%
Q4 2014$106,000
-58.6%
41,626
+6.1%
0.00%
-50.0%
Q2 2014$256,000
+8.0%
39,229
-21.6%
0.00%0.0%
Q4 2013$237,000
+149.5%
50,023
+173.5%
0.00%
+100.0%
Q2 2013$95,00018,2880.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 8,250,000$7,404,0003.11%
BVF INC/IL 4,777,381$4,288,0000.73%
NEA Management Company, LLC 7,789,644$7,011,0000.45%
Palo Alto Investors LP 6,974,854$6,260,0000.35%
Healthcare Value Capital, LLC 150,000$135,0000.22%
Frontier Wealth Management LLC 527,870$474,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,067,122$1,855,0000.06%
Baker Brothers Advisors 4,450,000$3,994,0000.03%
Noven Financial Group, Inc. 41,000$37,0000.03%
FRANKLIN STREET ADVISORS INC /NC 100,000$90,0000.02%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders